Journal ArticleOPEN ACCESS

Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

  • Spillane S
  • Baxi S
  • Torres A
  • et al.
The Oncologist (2020) 25(11) e1753-e1762
DOI: 10.1634/theoncologist.2020-0055
11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Real-world data enables evaluation of immune checkpoint inhibitor (ICI) use in advanced melanoma management. We examined characteristics and outcomes of ICI-treated patients with advanced melanoma and organ dysfunction (baseline and emergent).

Cite

CITATION STYLE

APA

Spillane, S., Baxi, S., Torres, A. Z., Lenis, D., Freedman, A. N., Mariotto, A. B., & Sharon, E. (2020). Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. The Oncologist, 25(11), e1753–e1762. https://doi.org/10.1634/theoncologist.2020-0055

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free